{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:04:54Z","timestamp":1788930294069,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["33219"],"award-info":[{"award-number":["33219"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["CMDO-2021"],"award-info":[{"award-number":["CMDO-2021"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012727","name":"Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec, Universit\u00e9 Laval","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["DOL342964"],"award-info":[{"award-number":["DOL342964"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e26968","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T23:10:28Z","timestamp":1709334628000},"page":"e26968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Investigating the alterations of endocannabinoidome signaling in the human small intestine in the context of obesity and type 2 diabetes"],"prefix":"10.1016","volume":"10","author":[{"given":"Volatiana","family":"Rakotoarivelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Allam-Ndoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Biertho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5944-7200","authenticated-orcid":false,"given":"Nicolas","family":"Flamand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4078-1908","authenticated-orcid":false,"given":"Alain","family":"Veilleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.heliyon.2024.e26968_bib1","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.CIR.0000158483.13093.9D","article-title":"Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation","volume":"111","author":"Dandona","year":"2005","journal-title":"Circulation"},{"issue":"7 Suppl","key":"10.1016\/j.heliyon.2024.e26968_bib2","first-page":"s176","article-title":"Obesity: definition, comorbidities, causes, and burden","volume":"22","author":"Apovian","year":"2016","journal-title":"Am. J. Manag. Care"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e26968_bib3","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/cells11121872","article-title":"Obesity: the fat tissue disease version of cancer","volume":"11","author":"Boubertakh","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26968_bib4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.dsx.2018.10.008","article-title":"Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention","volume":"13","author":"Tan","year":"2019","journal-title":"Diabetes Metabol. Syndr.: Clin. Res. Rev."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e26968_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26968_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3070","article-title":"Glucagon\u2010like peptide\u20101 receptor agonists in type 2 diabetes treatment: are they all the same?","volume":"35","author":"Gentilella","year":"2019","journal-title":"Diabetes\/metabolism research and reviews"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e26968_bib7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41574-020-0399-8","article-title":"Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus","volume":"16","author":"Deacon","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e26968_bib8","first-page":"430","volume":"5","author":"Fernandez","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e26968_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/mol.105.015040","article-title":"The cannabinoid CB1 receptor antagonist rimonabant (SR141716) Inhibits cell proliferation and increases markers of adipocyte Maturation in Cultured Mouse 3T3 F442A Preadipocytes","volume":"69","author":"Gary-Bobo","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e26968_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor Blocker, on weight and cardiometabolic risk Factors in overweight or obese PatientsRIO-North America: a Randomized Controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e26968_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S1516-44462009000200012","article-title":"The psychiatric side-effects of rimonabant","volume":"31","author":"Moreira","year":"2009","journal-title":"Brazilian Journal of Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e26968_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115261","article-title":"Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families","author":"Simard","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e26968_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106337","article-title":"Emerging class of omega-3 fatty acid endocannabinoids & their derivatives","volume":"143","author":"Watson","year":"2019","journal-title":"Prostaglandins & other lipid mediators"},{"key":"10.1016\/j.heliyon.2024.e26968_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2020.104973","article-title":"Intuitive eating is associated with elevated levels of circulating omega-3-polyunsaturated fatty acid-derived endocannabinoidome mediators","volume":"156","author":"Rochefort","year":"2021","journal-title":"Appetite"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e26968_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"Di Marzo","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e26968_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/cells10061279","article-title":"Role of the endocannabinoid system in the adipose tissue with Focus on energy metabolism","volume":"10","author":"Rakotoarivelo","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e26968_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11892-019-1248-9","article-title":"The expanded endocannabinoid system\/endocannabinoidome as a potential target for treating diabetes mellitus","volume":"19","author":"Veilleux","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.heliyon.2024.e26968_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cytogfr.2018.10.001","article-title":"Inflammation in human adipose tissues\u2013Shades of gray, rather than white and brown","volume":"44","author":"Rakotoarivelo","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e26968_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00418-018-1684-7","article-title":"Localization of cannabinoid receptors CB1, CB2, GPR55, and PPAR\u03b1 in the canine gastrointestinal tract","volume":"150","author":"Galiazzo","year":"2018","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e26968_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biochi.2017.05.019","article-title":"Impact of high-fat diet on the intestinal microbiota and small intestinal physiology before and after the onset of obesity","volume":"141","author":"Ara\u00fajo","year":"2017","journal-title":"Biochimie"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e26968_bib21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.2008.165886","article-title":"Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability","volume":"58","author":"Cani","year":"2009","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e26968_bib22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gut.2005.090472","article-title":"Endocannabinoid overactivity and intestinal inflammation","volume":"55","author":"Di Marzo","year":"2006","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e26968_bib23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/gut.2008.148791","article-title":"Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects","volume":"57","author":"Izzo","year":"2008","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26968_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s42255-018-0017-4","article-title":"Microbial regulation of organismal energy homeostasis","volume":"1","author":"Cani","year":"2019","journal-title":"Nat. Metab."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e26968_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.gastro.2005.05.026","article-title":"Differential expression of cannabinoid receptors in the human Colon: cannabinoids Promote epithelial Wound healing","volume":"129","author":"Wright","year":"2005","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e26968_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.heliyon.2024.e26968_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Classics Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26968_bib28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1194\/jlr.M021378","article-title":"Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC\/MS\/MS","volume":"53","author":"Fanelli","year":"2012","journal-title":"Journal of lipid research"},{"key":"10.1016\/j.heliyon.2024.e26968_bib29","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcjd.2017.10.003","article-title":"Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome","volume":"42","author":"Punthakee","year":"2018","journal-title":"Can. J. Diabetes"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26968_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1463-1326.2004.00374.x","article-title":"The anti\u2010obesity effect of rimonabant is associated with an improved serum lipid profile","volume":"7","author":"Poirier","year":"2005","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.heliyon.2024.e26968_bib31","series-title":"Antagonists of CB1 Receptor","author":"Piazza","year":"2018"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26968_bib32","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"Journal of hepatology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e26968_bib33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/jc.2006-1268","article-title":"Peroxisome proliferator-activated receptor \u03b3 and adipose tissue\u2014understanding obesity-related changes in regulation of lipid and glucose metabolism","volume":"92","author":"Sharma","year":"2007","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e26968_bib34","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1073\/pnas.082235799","article-title":"A missense mutation in human fatty acid amide hydrolase associated with problem drug use","volume":"99","author":"Sipe","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26968_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008792","article-title":"Biomarkers of endocannabinoid system activation in severe obesity","volume":"5","author":"Sipe","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e26968_bib36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.ijo.0802954","article-title":"Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)","volume":"29","author":"Sipe","year":"2005","journal-title":"Int. J. Obes."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e26968_bib37","first-page":"712","article-title":"Differential modulation of white adipose tissue endocannabinoid levels by n-3 fatty acids in obese mice and type 2 diabetic patients","volume":"1863","author":"Rossmeisl","year":"2018","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e26968_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/dom.12646","article-title":"Endocannabinoid regulation of \u03b2\u2010cell functions: implications for glycaemic control and diabetes","volume":"18","author":"Jourdan","year":"2016","journal-title":"Diabetes Obes. Metabol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26968_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/oby.20498","article-title":"Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study","volume":"22","author":"Abdulnour","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.heliyon.2024.e26968_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/824310","article-title":"Lifestyle interventions targeting body weight changes during the menopause transition: a systematic review","volume":"2014","author":"Jull","year":"2014","journal-title":"Journal of obesity"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e26968_bib41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-09-0643","article-title":"Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects","volume":"161","author":"Di Marzo","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e26968_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-511X-9-43","article-title":"Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients","volume":"9","author":"Annuzzi","year":"2010","journal-title":"Lipids Health Dis."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e26968_bib43","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1210\/jc.2007-0768","article-title":"The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms","volume":"92","author":"Pagano","year":"2007","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26968_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-10-129","article-title":"The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans","volume":"10","author":"Cable","year":"2011","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26968_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-511X-13-43","article-title":"The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes","volume":"13","author":"Cable","year":"2014","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.heliyon.2024.e26968_bib46","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3389\/fphys.2018.01913","article-title":"High fat diet increases circulating endocannabinoids accompanied by increased synthesis enzymes in adipose tissue","volume":"9","author":"Kuipers","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.heliyon.2024.e26968_bib47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0090-6980(02)00043-6","article-title":"Prostaglandin E synthase","volume":"68","author":"Murakami","year":"2002","journal-title":"Prostaglandins & other lipid mediators"},{"issue":"47","key":"10.1016\/j.heliyon.2024.e26968_bib48","doi-asserted-by":"crossref","first-page":"44877","DOI":"10.1074\/jbc.M206788200","article-title":"Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides","volume":"277","author":"Kozak","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"34","key":"10.1016\/j.heliyon.2024.e26968_bib49","doi-asserted-by":"crossref","first-page":"21181","DOI":"10.1074\/jbc.272.34.21181","article-title":"Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2","volume":"272","author":"Yu","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e26968_bib50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.bjp.0707486","article-title":"Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation","volume":"153","author":"Wright","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e26968_bib51","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1476-5381.2012.02122.x","article-title":"A re\u2010evaluation of 9\u2010HODE activity at TRPV 1 channels in comparison with anandamide: enantioselectivity and effects at other TRP channels and in sensory neurons","volume":"167","author":"De Petrocellis","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26968_bib52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s13075-015-0845-5","article-title":"Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner","volume":"17","author":"Lowin","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26968_bib53","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/cells10030586","article-title":"The endocannabinoid system and PPARs: Focus on their signalling crosstalk, action and transcriptional regulation","volume":"10","author":"Iannotti","year":"2021","journal-title":"Cells"},{"issue":"102","key":"10.1016\/j.heliyon.2024.e26968_bib54","article-title":"The role of peroxisome proliferator-activated receptor gamma (PPARG) in Adipogenesis: Applying knowledge from the fish Aquaculture Industry to Biomedical research","volume":"8","author":"Wafer","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e26968_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(03)00269-1","article-title":"Peroxisome-proliferator-activated receptor \u03b4 activates fat metabolism to prevent obesity","volume":"113","author":"Wang","year":"2003","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e26968_bib56","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/mol.63.5.983","article-title":"Activation and binding of peroxisome proliferator-activated receptor \u03b3 by synthetic cannabinoid ajulemic acid","volume":"63","author":"Liu","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26968_bib57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1124\/mol.105.019117","article-title":"Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor \u03b3 independently of cannabinoid receptors 1 and 2","volume":"70","author":"Rockwell","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e26968_bib58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"PPARG activation Primes human Monocytes into Alternative M2 macrophages with anti-inflammatory Properties","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cell Metabol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e26968_bib59","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1084\/jem.20140646","article-title":"GPR18 is required for a normal CD8\u03b1\u03b1 intestinal intraepithelial lymphocyte compartment","volume":"211","author":"Wang","year":"2014","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e26968_bib60","doi-asserted-by":"crossref","first-page":"E489","DOI":"10.1152\/ajpendo.00355.2017","article-title":"Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion","volume":"315","author":"Little","year":"2018","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10.1016\/j.heliyon.2024.e26968_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2019.03.011","article-title":"The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases","volume":"49","author":"Pascale","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e26968_bib62","first-page":"196","article-title":"Metformin and inflammation: its potential beyond glucose-lowering effect. Endocrine, metabolic & immune Disorders-drug Targets (formerly current drug Targets-immune","volume":"15","author":"Saisho","year":"2015","journal-title":"Endocrine & Metabolic Disorders)"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e26968_bib63","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.2337\/db06-0812","article-title":"Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity","volume":"55","author":"Bl\u00fcher","year":"2006","journal-title":"Diabetes"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024029992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024029992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:36:00Z","timestamp":1782246960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024029992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024029992"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26968","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the alterations of endocannabinoidome signaling in the human small intestine in the context of obesity and type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e26968"}}